Guizhou Bailing Group Pharmaceutical Co.,Ltd.’s Net Profit Rose 40.4% in First Quarter of 2023

Guizhou Bailing Group Pharmaceutical Co.,Ltd. (贵州百灵企业集团制药股份有限公司) (002424.SZ) reported a net profit of 91.9 million yuan in the first quarter of 2023, up 40.4% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, up 47.8% year-on-year.

At the end of the reporting period, it had 7.1 billion yuan in total assets and 3.1 billion yuan in total liabilities, with a liability-to-asset ratio of 43.7%.